<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.healthcaretimesdenmark.com/article/915459683-montavista-expands-mvshield-to-support-ubuntu-lts-platforms-beyond-standard-maintenance</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Times Denmark</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-28T13:00:00+00:00</news:publication_date>
        <news:title>MontaVista Expands MVShield to Support Ubuntu LTS Platforms Beyond Standard Maintenance</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/6405085-mv-corp-logo-1500x1500.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcaretimesdenmark.com/article/915656749-synklino-announces-first-patient-dosed-in-phase-1-trial-of-syn002-for-cmv-prevention-in-kidney-transplantation</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Times Denmark</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-28T07:30:00+00:00</news:publication_date>
        <news:title>Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/339f86f2-49a0-4d86-ad0d-d6ee8e7e69b2/small/brown-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcaretimesdenmark.com/article/915459548-zealand-pharma-to-participate-in-the-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Times Denmark</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T15:00:00+00:00</news:publication_date>
        <news:title>Zealand Pharma to participate in the Jefferies Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcaretimesdenmark.com/article/915384641-zealand-pharma-to-present-data-at-the-american-diabetes-association-s-2026-scientific-sessions</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Times Denmark</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T07:00:00+00:00</news:publication_date>
        <news:title>Zealand Pharma to Present Data at the American Diabetes Association&#39;s 2026 Scientific Sessions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png</image:loc>
        </image:image>
    </url>
</urlset>
